Degradation, insulin secretion, glucose-lowering and GIP additive actions of a palmitate-derivatised analogue of xenin-25
- 1 August 2012
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 84 (3), 312-319
- https://doi.org/10.1016/j.bcp.2012.04.015
Abstract
No abstract availableKeywords
Funding Information
- Department of Education and Learning, Northern Ireland
- University of Ulster Proof of Principle Funding Programme
This publication has 18 references indexed in Scilit:
- Loss of Incretin Effect Is a Specific, Important, and Early Characteristic of Type 2 DiabetesDiabetes Care, 2011
- Therapeutic potential of the original incretin hormone glucose-dependent insulinotropic polypeptide: diabetes, obesity, osteoporosis and Alzheimer's disease?Expert Opinion on Investigational Drugs, 2010
- Xenin-25 Potentiates Glucose-dependent Insulinotropic Polypeptide Action via a Novel Cholinergic Relay MechanismPublished by Elsevier BV ,2010
- Peripheral and Central Administration of Xenin and Neurotensin Suppress Food Intake in RodentsObesity, 2009
- The peptide hormone xenin induces gallbladder contractions in conscious dogsNeurogastroenterology & Motility, 2006
- GIP(Lys16PAL) and GIP(Lys37PAL): Novel Long-Acting Acylated Analogues of Glucose-Dependent Insulinotropic Polypeptide with Improved Antidiabetic PotentialJournal of Medicinal Chemistry, 2006
- Stimulatory effect of xenin-8 on insulin and glucagon secretion in the perfused rat pancreasRegulatory Peptides, 2003
- Characterization of a Novel Glucose-Responsive Insulin-Secreting Cell Line, BRIN-BD11, Produced by ElectrofusionDiabetes, 1996
- Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.JCI Insight, 1993
- Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) miceDiabetologia, 1981